¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sickel cell disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • notifiable disease
    ½Å°í´ë»óº´, ¹ß»ýº¸°íº´
  • nutritional deficiency disease
    ¿µ¾ç°áÇ̺´
  • nutritional disease
    ¿µ¾çº´, ¿µ¾ç¼ºÁúȯ
  • occlusive cerebrovascular disease
    Æó¼â³úÇ÷°üº´, Æó¼â³úÇ÷°üÁúȯ
  • occupational dental disease
    Á÷¾÷Ä¡°úº´
  • occupational disease
    Á÷¾÷º´
  • organic disease
    ±âÁúº´
  • Osgood-Schlatter disease
    ¿À½º±Â-½¶¶óÅͺ´
  • obstructive pulmonary disease
    Æó¼âÆóº´
  • Owren¡¯s disease
    ¿Àºê·»º´
  • phytanic acid storage disease
    ÇÇź»êÃàÀûº´
  • Pick disease
    ÇȺ´
  • pigeon breeder¡¯s disease
    ºñµÑ±â»çÀ°ÀÚº´
  • pandemic disease
    ¹üÀ¯Çິ
  • pneumatic hammer disease
    ¾ÐÂø°ø±âÇØ¸Óº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • polycystic kidney disease
    ¹µÁÖ¸Ó´ÏÄáÆÏº´, ´Ù³¶ÄáÆÏº´
  • posttransplant lymphoproliferative disease
    À̽ÄÈĸ鿪Áõ½Äº´
  • prenatal disease
    Ãâ»ýÀüº´
  • primary pigmented nodular adrenocortical disease
    ÀÏÂ÷»ö¼ÒÄ§Âø°áÁ¤ºÎ½Å°ÑÁúº´
  • professional disease
    Á÷¾÷º´
  • protozoan disease
    ¿øÃ溴
  • psychosomatic disease
    Á¤½Å½Åüº´
  • pulmonary disease
    Æóº´
  • pulseless disease
    ¹«¸Æ¹Úº´, ¹«¸Æº´
  • pyramidal disease
    ÇǶó¹Ô½Å°æ·Îº´, Ãßü½Å°æ·Îº´
  • quarantinable disease
    °Ë¿ªÁúȯ
  • rat-bite disease
    Áã¹°±âº´
  • Raynaud¡¯s disease
    ·¹À̳뺴
  • recessive hereditary disease
    ¿­¼ºÀ¯Àüº´
  • renal disease
    ÄáÆÏº´, ½ÅÀ庴
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • helper cell
    º¸Á¶¼¼Æ÷
  • helper cell
    Á¶·Â¼¼Æ÷, º¸Á¶¼¼Æ÷
  • helper cell activity
    Á¶·Â¼¼Æ÷´É, º¸Á¶¼¼Æ÷´É
  • hematopoietic cell transplantation
    Á¶Ç÷¼¼Æ÷À̽Ä(¡­á¬øàì¹ãÕ)
  • hematopoietic stem cell
    Á¶Ç÷°£¼¼Æ÷
  • hemolytic plaque-forming cell
    ¿ëÇ÷¹Ý Çü¼º¼¼Æ÷, ¿ëÇ÷ÇöóÅ© Çü¼º¼¼Æ÷
  • hensens cell
    ¹Ù±ù°æ°è¼¼Æ÷
  • hepatic cell
    °£¼¼Æ÷(ÊÜá¬øà).
  • hepatic cell cord
    °£¼¼Æ÷ÁÙ, °£¼¼Æ÷»è(¡­ßã).
  • heteroploid cell line
    À̼öü¼¼Æ÷°è
  • heterotrophic cell
    Á¾¼Ó¿µ¾ç¼¼Æ÷.
  • high peroxidase cell
    °íÆä·Ï½Ã´Ù¾ÆÁ¦¼¼Æ÷
  • hilus cell tumor
    ¹®¼¼Æ÷Á¾
  • hilus cell ³ª
    ¹®¼¼Æ÷(Ú¦á¬øà).
  • horny cell
    °¢Áú¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • cytomegalic inclusion disease =cid
    °Å´ë¼¼Æ÷¼º ºÀÀÔüº´(¡­ËÝÓÞàõÜæìýô÷ Ü»), °Å´ë¼¼Æ÷ ºÀÀÔüÁúȯ(¡­òðü´)
  • degenerative brain disease
    ÅðÇ༺ ³úÁúȯ.
  • degenerative brain disease
    ÅðÇ༺ ³úÁúº´(÷Üú¼àõ ÒàòðÜ»).
  • degenerative disease
    ÅðÇ༺ Áúȯ.
  • degenerative heart disease
    ÅðÇ༺ ½ÉÁúȯ.
  • degenerative joint disease
    ÅðÇ༺ °üÀý Áúȯ(÷Üú¼àõμï½.
  • degenerative joint disease
    ÅðÇ༺ °üÀýÁúȯ(¡­Î¼ï½òðü´)
  • dejerine-sottas disease
    µ¥Àú¸°-¼ÒŸ½ºº´ (¡­Ü»)
  • demyelinating disease
    Å»¼öÃÊ(¼º) Áúȯ(÷­âÐôúàõòðü´).
  • demyelinating disease
    Å»¼öÃÊ(¼º) Áúȯ(÷­âÐôúàõòðü´)
  • demyelination disease
    Å»¼öÃÊÁúȯ.
  • dense-deposit disease
    °í¹Ðµµ Ä§Âøº´(ÍÔÚËÓøöØó·Ü»)
  • depression spectrum disease
    ¿ì¿ï ½ºÆåÆ®·³ Áúȯ(éØê¦ ~ òðü´)
  • developmental disease =growth abnor mal ity
    ¹ß´ÞÀÌ»ó(¡­ì¶ßÈ).
  • dialysis-associated cystic disease of kidney
    ½Å(ãì)ÀÇ Åõ¼®(÷âà°) ¿¬°ü¼º ³¶¼ºÁúȯ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
ED early-decision [applicant]; early differentiation; ectodermal dysplasia; ectopic depolarization; eff...
GSD genetically significant dose; Gerstmann-Straussler disease; glutathione synthetase deficiency; glyco...
HLD hepatolenticular degeneration; herniated lumbar disk; Hippel-Lindau disease; hypersensitivity lung d...
IBD inflammatory bowel disease; irritable bowel disease
IPD idiopathic Parkinson disease; idiopathic protracted diarrhea; immediate pigment darkening; increase ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
COAD Chronic Obstructive Airway Disease
COLD Chronic Obstructive Lung Disease
COPD Chronic Obstructive Lung Disease
COPD Chronic Obstructive Pulmonary Disease
CRDQ Chronic Respiratory Disease Questionnaire
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • rheumatic disease
    ·ù¸¶Æ¼¼º Áúȯ, ·ù¸¶Æ¼½º¼º Áúȯ
  • rheumatic valvular disease
    ·ù¸¶Æ¼½º¼º ÆÇ¸· Áúȯ
  • rheumatoid disease
    ·ù¸¶Æ¼½º¾ç Áúȯ
    Ư¡À¸·Î¼­ Ȱ¸·¿°. °üÀý ÆÄ±«, °üÀý º¯Çü µîÀÇ °üÀýħ½ÀÀ» ÁÖ·Î ÇÏ´Â Àü½Å¼º Áúȯ.
  • Riga-Fede disease
    ¸®°¡-Æäµ¥º´
    ¼Ò¾ÆÀÇ ¼³¼Ò´ëÀÇ À°¾ÆÁ¾À¸·Î ÇÏ¾Ç ÁßÀýÄ¡¿¡ ÀÇÇÑ ¸¶Âû ÈÄ¿¡ »ý±ä´Ù.
  • saccharine disease
    »çÄ«¸° º´
    ½ÄÀ̼º ¼¶À¯¿Í ´Ü¹éÁúÀ» Á¦°ÅÇϰí Á¤Á¦ÇÑ ÇÔ¼öź¼Ò ½Ä»ç¸¦ °úµµÇÏ°Ô ¼·ÃëÇÏ¿© »ý±â´Â Áúº´¿¡ ´ëÇÏ¿© Á¦Ã¢µÈ ¿ë¾îÀÌ´Ù. À̰Ϳ¡´Â ´ç´¢º´, ½ÉÇ÷°ü Áúȯ, º¯ºñ, ºñ¸¸Áõ ¹× ¼ÒÈ­¼º ±Ë¾ç µîÀÌ Æ÷ÇԵȴÙ.
  • salivary gland disease
    Ÿ¾×¼± Áúȯ
  • Saunders' disease
    »ç¿î´õÁî º´
    Á¥¸ÔÀÌ¿¡°Ô °ú·®ÀÇ Åº¼öÈ­¹° À½½ÄÀ» ÁÖ¾úÀ» ¶§ ÀϾ´Â ¼ÒÈ­ Àå¾Ö¿¡¼­ º¼ ¼ö ÀÖ´Â À§ÇèÇÑ Áõ»ó. ±¸Åä, ³ú Áõ»ó, ¼øÈ¯ Àå¾Ö°¡ Ư¡ÀÌ´Ù.
  • Schamberg's disease ¸¸¼º, ¹«Áõ»ó¼º ÇǺΠÁúȯÀ¸·Î »çÃá±â¿Í Àå³â±âÀÇ ³²ÀÚ¿¡°Ô ¹ß»ýÇÑ´Ù. ¾Õ Á¤°­ÀÌ, ¹ß¸ñ, ¹ß, ¹ß°¡¶ô µî¿¡ ±¹ÇÑÇÏ¿© ³ªÅ¸³ª´Â µî»ö ¶Ç´Â ´ãȲ °¥»öÀÇ °¡ÀåÀÚ¸®¿¡ Àû»öÁ¡À» °¡Áø ¹Ý»ó ¹ßÁøÀ» Ư¡À¸·Î ÇÑ´Ù.

    Schanz's syndrome

    ¼¢Áî ÁõÈıº
    ÇǷΰ¨, ôÃß µ¹±âÀÇ ¾ÐÅë, º¹¿ÍÀ§¿¡¼­ÀÇ µ¿Åë, ôÃß ¸¸°î µî, ôÃßÀÇ ¼è¾àÀ» ³ªÅ¸³»´Â ÀÏ·ÃÀÇ ÁõÈÄ.
  • Schilder's disease
    ½¯´õº´
    1. 1912³â¿¡ ±âÀçÇÑ ¼Ò¾Æ ¹× ÀþÀºÀÌ¿¡°Ô ÀϾ´Â ¿øÀÎ ºÒ¸íÀÇ µå¹® ÁúȯÀ¸·Î¼­, ÁÖ·Î ´ë³ú ¹Ý±¸¸¦ ħ¹üÇϸç, Á¶±â¿¡ Àå´Ô, ±Í¸Ó°Å¸®, °¨°¢Àå¿¡ µîÀÇ Áõ»óÀÌ ³ªÅ¸³­´Ù. 2. ¹éÁú³úÁõÀÇ ¾Æ±Þ¼º ¶Ç´Â ¸¸¼ºÇüÀ¸·Î ¼Ò¾Æ ¹× û³â¿¡°Ô¼­ º¼ ¼ö ÀÖ´Ù. ÀÓ»óÁõ»óÀ¸·Î´Â ½Ç¸í, ³­Ã», ¾çÃø¼º °æ·Ã, ÁøÇ༺ Á¤½ÅȲÆó µîÀÌ ³ªÅ¸³­´Ù. ´ë³ú ¹éÁúÀÇ ±¤¹üÇÑ ÆÄ±«°¡ ÀÖ°í, °øµ¿ÀÌ Çü¼ºµÈ´Ù. º¸Åë »ê¹ßÀûÀ¸·Î ¹ß»ýÇϳª °¡Á·¼ºÀÇ º´ÇüÀ¸·Îµµ º¸°íµÇ¾î ÀÖ´Ù.
  • Schmorl's disease
    ½¬¸ð¸¦ º´
    1. ÀÎÁ¢ÇÑ º¹Ã¼ºÎ¿¡ÀÇ ¼öÇÙ Å»Ãâ.
  • Scholz's disease
    ¼ñÃ÷ º´
    ¹éÁú ³úÁõÀÇ °¡Á· ¼ºÇüÀ¸·Î ¹Ý¼º ¿­¼º À¯Àü. 8¼¼ °æ¿¡ ½ÃÀÛÇÏ¿© ³ú¹éÁúÀÇ Å»¼öÈ­, °¨°¢¼º ½Ç¾îÁõ, ÇÇÁú¼º ½Ç¸í, ³­Ã», Çã¾à, »çÁöÀÇ °æ·Ã, ¿ÏÀü ¸¶ºñ, Ä¡¸Å°¡ Ư¡ÀÌ´Ù.
  • seasonal disease
    °èÀýº´
    °èÀý¿¡ µû¶ó ¹ß»ýÇÏ´Â º´ÀÇ ÃÑĪ. °èÀýÀÇ º¯È­°¡ º´À» ÀÏÀ¸Å²´Ù´Â °ÍÀ» óÀ½ ±â·ÏÇÑ »ç¶÷Àº È÷Æ÷Å©¶óÅ×½º¿´´Âµ¥, À̸¦ ±Ù´ë ÀÇÇÐÀûÀÎ ¹æ¹ýÀ¸·Î ¿¬±¸ÇÑ »ç¶÷Àº µ¶ÀÏÀÇ µ¥ ·ç´õ¿´´Ù. ±×´Â ±â´Ü ±³Ã¼ ¶§ÀÇ Àü¼± Åë°ú¿Í °¢Á¾ Áúº´°úÀÇ °ü·ÃÀ» Åë°èÇÐÀûÀ¸·Î Á¶»çÇÏ¿´À¸¸ç, ƯÈ÷ ºÏ¹Ý±¸ÀÇ °èÀý°ú °ü°è°¡ ±íÀº Áúº´ÀÇ ¿¬°£ºÐÆ÷Ç¥´Â °èÀýº´ ͏°´õÀÇ ½ÃÃʷμ­ À¯¸íÇÏ´Ù. ¾î¶² º´À» °èÀýº´À¸·Î Ãë±ÞÇϱâ À§Çؼ­´Â, ±× º´ÀÇ À¯¹ßÀÎÀÚ ¶Ç´Â ±× º´À» Àü¿°½ÃŰ´Â À§»ý °ïÃæ µîÀÌ °èÀýÀûÀ¸·Î º¯µ¿Çϰí ÀÖ´Ù´Â Á¡, ¶Ç´Â Àΰ£ ÀÚü°¡ ±× º´¿¡ °É¸®±â ½¬¿î »óŰ¡ °èÀý¿¡ ÀÇÇØ¼­ Á¿ìµÈ´Ù´Â Á¡ µîÀÌ ¾î¶»°Ô ¼­·Î ¾ôÇô ÀÖ´ÂÁö Á¶»çÇÒ Çʿ䰡 ÀÖ´Ù. Çѱ¹ÀÇ °æ¿ì, ¾î¸°ÀÌÀÇ ¼ÒÈ­±â º´À̳ª ´Üµ¶ µîÀÇ ÇǺΠÁúȯÀº ¿©¸§¿¡ ¸¹°í, °Ü¿ï¿¡¼­ º½¿¡ À̸£·¯ Â÷°í ¸Þ¸¶¸¥ ±âÈÄÀÏ ¶§¿¡´Â °¨±â, Æó·Å, ±Þ¼º ±â°üÁö¿° µîÀÌ ¸¹´Ù.
  • self limited disease
    ÀÚ±â ÇÑÁ¤¼º Áúȯ
    Áúȯ ÀÚüÀÇ ¼ºÁú ¶§¹®¿¡ ÀÏÁ¤Çϰí ÇÑÁ¤µÈ °æ°í¸¦ ÃëÇÏ´Â Áúȯ.
  • sexually transmitted disease
    ¼º Àü¿°¼º Áúȯ
    Åë»óÀûÀÎ ¼º±³¿¡ ÀÇÇÑ ¼ºº´À» Æ÷ÇÔÇÏ¿©, ¼º±³´Â ¾Æ´ÏÁö¸¸ À¯»çÇÑ ¼º ÇàÀ§·Î °¨¿°µÇ´Â ¸ðµç Áúȯ. ¼º¿¡ ´ëÇÑ »çȸ °ü½ÀÀº Áö³­ ¼ö ½Ê ³â¿¡ °ÉÃÄ ¸¹ÀÌ º¯È­ÇÏ¿´À¸¸ç, 1970³â´ë¿¡ À̸£·¯ ¼º ÇàÀ§ÀÇ ´Ù¾ç¼ºÀÌ µÎµå·¯Áö°Ô ³ªÅ¸³µ´Ù. Áï, À̼º°£ÀÇ ¼º±³»Ó¸¸ ¾Æ´Ï¶ó µ¿¼º°£¿¡ ÇàÇÏ¿©Áö´Â ¿©·¯ ÇüÅÂÀÇ ¼º ÇàÀ§, ¿©·¯ »ó´ëÀÚ¿ÍÀÇ ¼º °ü°è, ´Ù¾çÇÑ ¼º ±â±³ ¹× ±¸°­ ¼º±â ¼º ÇàÀ§ µî ´Ù¾çÇØÁ³À¸¸ç, ÀÌ¿¡ µû¶ó °¨¿°ÀÇ Á¾·ùµµ Áõ°¡ÇÏ¿´´Ù. ¶ÇÇÑ °¨¿° °æ·Îµµ Åë»óÀû ¼º±³ ¿Ü¿¡ ±¸°­ ¹× ¼º±â¿¡ÀÇ ÀÔ¸ÂÃã¿¡ ÀÇÇÑ °æ±¸ °¨¿°, µ¿¼º¾Ö ³²¼º°£¿¡ ÇàÇÏ¿©Áö´Â Ç×¹® ¼º±³ ¹× ¿©·¯ »ç¶÷ÀÌ ¾î¿ï·Á ºÒ°áÇÏ°Ô À̺ÎÀÚ¸®¸¦ °°ÀÌ »ç¿ëÇÏ´Â µ¥¼­ ¿À´Â ±â»ýÃæ °¨¿° µî ¿©·¯ °¡Áö°¡ ÀÖ´Ù. ¼º Àü¿°¼º ÁúȯÀ» ÀÏÀ¸Å°´Â º´¿øÃ¼µµ ´Ù¾çÇÏ¿©, ´ëº°ÇØ º¸¸é, ¼¼±Õ, ¹ÙÀÌ·¯½º, Ŭ¶ó¹Ìµð¾Æ Æ®¶óÄÚ¸¶Æ¼½º
  • silo-filler's disease
    »çÀÏ·Î Ãæ¸¸ °¡½ºº´
    ¶§¶§·Î ±Þ¼º Æó ºÎÁ¾À» ¼ö¹ÝÇÏ´Â ÆóÀÇ ¿°ÁõÀ¸·Î, »çÀϷο¡ ¸ðÀÎ Àڱؼº °¡½ºÀÇ ÈíÀÔÀÌ ¿øÀÎÀÌ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
cell adhesion kinase <enzyme> From hela cells; involved in cell-cell interactions; genbank l20817
Registry number: EC 2.7.1.-
Synonym: cak protein
(26 Jun 1999)
cell adhesion molecule <molecular biology> Although this could mean any molecule involved in cellular adhesive phenomena, it has acquired a more restricted sense, namely a molecule on the surface of animal tissue cells, antibodies (or Fab fragments) against that specifically inhibit some form of intercellular adhesion.
Examples are Liver Cell Adhesion Molecule and Neural Cell Adhesion Molecule, both named from tissues in which first detected, although their occurrence is not in fact restricted to these.
Acronym: CAM
(26 Nov 1998)
cell adhesion molecules Surface ligands, usually glycoproteins, that mediate cell-to-cell adhesion. Their functions include the assembly and interconnection of various vertebrate systems, as well as maintenance of tissue integration, wound healing, morphogenic movements, cellular migrations, and metastasis.
(12 Dec 1998)
cell adhesion molecules, neuronal Surface ligands that mediate cell-to-cell adhesion and function in the assembly and interconnection of the vertebrate nervous system. These molecules promote cell adhesion via a homophilic mechanism. These are not to be confused with ncam (neural cell adhesion molecule), now known to be expressed in a variety of tissues and cell types in addition to nervous tissue.
(12 Dec 1998)
cell adhesion molecules, neuron-glia Cell adhesion molecules that mediate neuron-neuron adhesion and neuron-astrocyte adhesion. They are expressed on neurons and schwann cells, but not astrocytes and are involved in neuronal migration, neurite fasciculation, and outgrowth. Ng-cam is immunologically and structurally distinct from ncam (neural cell adhesion molecules).
(12 Dec 1998)
cell aggregation The phenomenon by which dissociated cells intermixed in vitro tend to group themselves with cells of their own type.
(12 Dec 1998)
cell aging The decrease in the cell's ability to proliferate with the passing of time. Each cell is programmed for a certain number of cell divisions and at the end of that time proliferation halts. The cell enters a quiescent state after which it experiences cell death via the process of apoptosis.
(12 Dec 1998)
cell behaviour <cell biology> General term for activities of whole cells such as movement, adhesion and proliferation, by analogy with animal behaviour.
(18 Nov 1997)
cell biology <study> The study of the internal workings of cells at the microscopic and molecular level - it is closely linked to molecular biology.
(16 Dec 1997)
cell body Used in reference to neurons, the main part of the cell around the nucleus excluding long processes such as axons and dendrites.
(18 Nov 1997)
cell-bound antibody A term used for antibody on the surface of cells that may be bound either through antigen combining sites or other sites such as the Fc region.
(05 Mar 2000)
renal cell cancer Cancer that develops in the lining of the renal tubules, which filter the blood and produce urine. Also called renal cell carcinoma.
(12 Dec 1998)
renal cell carcinoma <oncology, tumour> The most common form of kidney cancer which occurs when the cells lining the renal tubule undergo cancerous changes. There are approximately 18,000 new cases of renal cell carcinoma (hypernephroma) per year in the U.S. With about 8,000 deaths annually.
Smoking is considered a major risk factor. Kidney dialysis patients are at increased risk for the development of hypernephroma. Family history for renal cell carcinoma is also considered a risk factor.
Symptoms include haematuria, flank pain, abdominal pain, back pain, weight loss and abdominal swelling.
(27 Sep 1997)
cell bridges Slender cytoplasmic strands connecting adjacent cells; in histological sections of the epidermis and other stratified squamous epithelia, the bridge's are processes attached by a desmosome and are shrinkage artifacts of fixation; true bridge's with cytoplasmic confluence exist between incompletely divided germ cells.
Synonym: cell bridges, cytoplasmic bridges.
(05 Mar 2000)
cell centre Microtubule organising centre of the cell, the pericentriolar region.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
ÅëÇÕ°Ë»ö ¿Ï·á